Hutch News
Results per Page:
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
A new path forward: A potential route to effective HIV vaccines
From the Overbaugh Lab, Human Biology Division
How studies of coronavirus immunity can inform better vaccines, treatments
Scientists look for broad-acting antibodies that could protect against new variants of SARS-CoV-2 — and maybe a future SARS-3
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
All immunogens are not created equal
From the Stamatatos lab, Vaccine and Infectious Disease Division
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Screening with bioinformatics for new dengue cross-serotype antibodies
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Creating antibodies with antibodies
From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
Machine learning predicts HIV pseudovirus antibody neutralization
From the Gilbert group, Vaccine and Infectious Disease Division
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
Could an infant’s blood sample help model a better HIV vaccine?
Tracing the evolution of a baby’s special HIV-blocking protein
Cutting-edge approach maps HIV's escape routes
Atlas of immune-evading HIV mutations could inform design of new treatments, vaccines
Modified HIV immunogens engage neutralizing antibody precursors
From the Stamatatos lab, Vaccine and Infectious Disease Division
HIV researcher Cassandra Simonich receives 2018 Graduate School Medal from University of Washington
Award honors her contributions to research and dedication to improving the lives of medically underserved populations
New library of HIV mutants could inform vaccine design
Laboratory manipulation of the AIDS-causing virus reveals evolutionary ‘dead-ends’
Empowering ‘millions of women’ against HIV
AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands
A new path to an AIDS vaccine?
A ‘landmark’ clinical trial called the AMP study launches on three continents to test HIV-blocking super antibodies